These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30709830)
21. Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study. AbuHilal M; Walsh S; Shear N J Cutan Med Surg; 2016 Jul; 20(4):313-6. PubMed ID: 26848145 [TBL] [Abstract][Full Text] [Related]
22. Apremilast for the management of moderate to severe plaque psoriasis. Vangipuram R; Alikhan A Expert Rev Clin Pharmacol; 2017 Apr; 10(4):349-360. PubMed ID: 28276777 [TBL] [Abstract][Full Text] [Related]
23. Off-label studies on apremilast in dermatology: a review. Maloney NJ; Zhao J; Tegtmeyer K; Lee EY; Cheng K J Dermatolog Treat; 2020 Mar; 31(2):131-140. PubMed ID: 30935262 [No Abstract] [Full Text] [Related]
24. Apremilast: A Review in Psoriasis and Psoriatic Arthritis. Deeks ED Drugs; 2015 Aug; 75(12):1393-403. PubMed ID: 26220911 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Papp K; Cather JC; Rosoph L; Sofen H; Langley RG; Matheson RT; Hu C; Day RM Lancet; 2012 Aug; 380(9843):738-46. PubMed ID: 22748702 [TBL] [Abstract][Full Text] [Related]
26. [Gastrointestinal side effects of apremilast : Characterization and management]. Pinter A; Beigel F; Körber A; Homey B; Beissert S; Gerdes S; Staubach-Renz P; Radtke MA; Mössner R Hautarzt; 2019 May; 70(5):354-362. PubMed ID: 30937481 [TBL] [Abstract][Full Text] [Related]
27. Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis. Haber SL; Hamilton S; Bank M; Leong SY; Pierce E Ann Pharmacother; 2016 Apr; 50(4):282-90. PubMed ID: 26783350 [TBL] [Abstract][Full Text] [Related]
28. Drug safety evaluation of apremilast for treating psoriatic arthritis. Busa S; Kavanaugh A Expert Opin Drug Saf; 2015 Jun; 14(6):979-85. PubMed ID: 25827658 [TBL] [Abstract][Full Text] [Related]
30. A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast. Chiricozzi A; Caposiena D; Garofalo V; Cannizzaro MV; Chimenti S; Saraceno R Expert Rev Clin Immunol; 2016; 12(3):237-49. PubMed ID: 26692125 [TBL] [Abstract][Full Text] [Related]
31. Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis. Papadavid E; Rompoti N; Theodoropoulos K; Kokkalis G; Rigopoulos D J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1173-1179. PubMed ID: 29388335 [TBL] [Abstract][Full Text] [Related]
32. Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. Radi G; Campanati A; Diotallevi F; Molinelli E; Offidani A G Ital Dermatol Venereol; 2019 Apr; 154(2):166-169. PubMed ID: 30229640 [TBL] [Abstract][Full Text] [Related]
33. Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials. Thaçi D; Kimball A; Foley P; Poulin Y; Levi E; Chen R; Feldman SR J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):498-506. PubMed ID: 27538241 [TBL] [Abstract][Full Text] [Related]
34. Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis. Torres T; Puig L Am J Clin Dermatol; 2018 Feb; 19(1):23-32. PubMed ID: 28597182 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study. Strober B; Bagel J; Lebwohl M; Stein Gold L; Jackson JM; Chen R; Goncalves J; Levi E; Callis Duffin K J Drugs Dermatol; 2017 Aug; 16(8):801-808. PubMed ID: 28809995 [TBL] [Abstract][Full Text] [Related]
36. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). Rich P; Gooderham M; Bachelez H; Goncalves J; Day RM; Chen R; Crowley J J Am Acad Dermatol; 2016 Jan; 74(1):134-42. PubMed ID: 26549249 [TBL] [Abstract][Full Text] [Related]